S100A9 mediates neutrophil adhesion to fibronectin through activation of beta 2 integrins von Anceriz, N, Vandal, K, Tessier, P A

Volltext

190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale von Paturel, C.L., Anceriz, N., Eyles, J., Lapointe, J-M., Denis, C., Breso, V., Courtois, R., Augier, S., Brown, L., Luheshi, N., Watkins, A., Cooper, Z.A., Tu, E., Vivier, E., Fraenkel, P.G.

Volltext